Palatin Technologies, Inc. Common Stock

PTNNASDAQ • USD
ThemeBiotech - Drug Development›Rare Disease Therapeutics
6.02 USD
↘ 0.47 (7.24%)AT CLOSE (03:59 PM EDT)
6.02
↘ 0.00 (0.08%)
POST MARKET (AS OF 04:00 PM EDT)
Post Market
AS OF 04:00 PM EDT
6.02
↘ 0.00 (0.08%)
🟢Market: OPEN

Palatin Technologies, Inc. Common Stock (PTN) trades at $6.02 per share. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, PTN appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Oct 16, 2026.

Open?$6.93
High?$6.93
Low?$6.00
Prev. Close?$6.49
Volume?39.2K
Avg. Volume?87.8K
VWAP?$6.28
Rel. Volume?0.45x
Bid / Ask
Bid?$5.15 × 100
Ask?$7.32 × 100
Spread?$2.17
Midpoint?$6.24
Valuation & Ratios
Market Cap?11.6M
Shares Out?1.8M
Float?1.6M
Float %?92.0%
P/E Ratio?N/A
P/B Ratio?1.73
EPS?-$4.70
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor (MCR) system. Its product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical need and commercial potential. It is also developing, dependent on resources for development activities, MC1R agonist products, with potential to treat inflammatory and autoimmune diseases, such as dry eye disease, which is also known as keratoconjunctivitis sicca, uveitis, diabetic retinopathy, and inflammatory bowel disease. It has one operating segment life science.
Themes
Biotech - Drug Development›Rare Disease Therapeutics
Employees
25
Market Cap
11.6M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.palatin.com
Listed
1993-11-04
Address
4B CEDAR BROOK DRIVE
CRANBURY, NJ 08512
Phone: 609-495-2200
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
45
Piotroski F-Score?0/9Weak
Altman Z-Score?-73.91Distress
Confidence?54%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?22.30%Squeeze Risk
Short Interest?364.9K
Days to Cover?8.0
Free Float1.6M
Avg Daily Volume45.6K
Settlement Date2026-09-30
Financial Health
Current Ratio?4.61Strong
Quick Ratio?4.61Strong
Cash Ratio?4.23Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
82
1.73CHEAP▾
P/S?
Peers
100
S&P
89
0.88CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.5CHEAP▾
EV/Sales?
Peers
100
S&P
97
0.31CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-125.3%WEAK▾
ROA?
S&P
3
-98.3%WEAK▾
Cash Flow & Enterprise
FCF?$-13584569
Enterprise Value?$4.1M
Fundamentals ratios updated end of day
MarketsMoversWatchlist